Takeda Pharmaceutical Company Limited

4502・Prime Market・Pharmaceuticals

Official website

Takeda Pharmaceutical Company Limited

4502・Prime Market・Pharmaceuticals

Official website

Takeda Pharmaceutical Company Limited4502

Reference Indicators

Market Cap

88,297¥100M

P/E (Forecast)

53.2x

P/B

1.2x

Dividend Yield (Forecast)

3.68%

ROE

-2.1%

EV/EBITDA

17.3x

Financial Summary

Unit: ¥M

Item	2022Mar 2022	2023Mar 2023	2024Mar 2024	2025Mar 2025	2026Mar 2026
Net Sales	3,569,006	4,027,478	4,263,762	4,581,551	4,505,720
Cost of Sales	1,106,846	1,244,072	1,426,678	1,580,217	1,571,588
Gross Profit	2,462,160	2,783,406	2,837,084	3,001,334	2,934,132
SG&A Expenses	886,361	997,309	1,053,819	1,104,766	1,084,215
Operating Income	460,844	490,505	214,075	342,586	6,217
Pre-tax Income	302,571	375,090	52,791	175,084	-142,355
Income Taxes	72,405	58,052	-91,406	66,941	9,770
Net Income	230,059	317,017	144,067	107,928	-152,390
EBITDA	1,043,995	1,154,905	942,077	1,103,982	727,344
Gross Margin	69.0%	69.1%	66.5%	65.5%	65.1%
Operating Margin	12.9%	12.2%	5.0%	7.5%	0.1%
ROA	1.7%	2.3%	1.0%	0.8%	-1.0%
ROE	4.0%	5.0%	2.0%	1.6%	-2.1%

Segment Performance

Unit: ¥M

2026

Segment	Net Sales	Operating Income	Operating Margin
医薬品事業	0	0	0.0%